Prosecution Insights
Last updated: May 29, 2026

Dentons US LLP (Joel Bock)

7 pending office actions • 3 clients • 7 examiners • 3 art units • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
3
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (57%)
2
Easy (29%)
1
Unknown (14%)

Rejection Statute Mix

BucketCases
§103 only4 (57%)
§112 only2 (29%)
No statute on record1 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
14% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
6
Mechanical / Eng
86% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MUROMOTO JR, ROBERT H 1 66.5% -11.0%
BYRD, BRIGID K 1 70.6% +50.2%
ZEMAN, ROBERT A 1 54.0% +27.8%
SCHERBEL, TODD J 1 76.2% +51.6%
BACHMAN, LINDSEY MICHELE 1 48.3% +41.6%
HOLLM, JONATHAN ADAM 1 49.1% +54.4%
NEMER, OSAMA MOHAMMAD 1 64.9% +53.8%

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17826454 CURVED SUTURE NEEDLE EXTENSION BACHMAN, LINDSEY MICHELE 131d overdue
17471017 TAPERED TRANSITION PORTION FOR SUTURE NEEDLES HOLLM, JONATHAN ADAM 112d overdue
17877126 SYSTEMS AND METHODS FOR SUTURING SCHERBEL, TODD J 66d overdue
17470967 CURVED SUTURE NEEDLES HAVING A NON-SMOOTH PROFILE NEMER, OSAMA MOHAMMAD 50d overdue
17945812 SUTURE NEEDLES WITH FLEXIBLE AND NON-FLEXIBLE COMPONENTS BYRD, BRIGID K 8d overdue
17896847 COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OR PREVENTION OF CONDITIONS ASSOCIATED WITH HYPERPROLIFERATIVE CELLULAR DIVISION, DIABETES, IMMUNODEFICIENCY DISEASES, ALZHEIMER'S DISEASE OR AUTOIMMUNE DISEASES, AND TESTING SYSTEM AND METHOD ZEMAN, ROBERT A 26d

Client Portfolio (3 clients)

Top Art Units

Art UnitApps
37715
37321
16451

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19075687 LOW PROFILE MEDICAL KIT Phokus Research Group, LLC MUROMOTO JR, ROBERT H 3732 Other Non-Final OA 19d overdue Pending Mar 10, 2025
17945812 SUTURE NEEDLES WITH FLEXIBLE AND NON-FLEXIBLE COMPONENTS Ergosurgical Group Corp. BYRD, BRIGID K 3771 §103 Final Rejection 8d overdue Pending Sep 15, 2022
17896847 COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OR PREVENTION OF CONDITIONS ASSOCIATED WITH HYPERPROLIFERATIVE CELLULAR DIVISION, DIABETES, IMMUNODEFICIENCY DISEASES, ALZHEIMER'S DISEASE OR AUTOIMMUNE DISEASES, AND TESTING SYSTEM AND METHOD Chai Foundation For Medical Research & Life Extension, Inc. ZEMAN, ROBERT A 1645 §112 Final Rejection 26d Pending Aug 26, 2022
17877126 SYSTEMS AND METHODS FOR SUTURING Ergosurgical Group Corp. SCHERBEL, TODD J 3771 §103 Final Rejection 66d overdue Pending Jul 29, 2022
17826454 CURVED SUTURE NEEDLE EXTENSION Ergosurgical Group Corp. BACHMAN, LINDSEY MICHELE 3771 §112 Final Rejection 131d overdue Pending May 27, 2022
17471017 TAPERED TRANSITION PORTION FOR SUTURE NEEDLES Ergosurgical Group Corp. HOLLM, JONATHAN ADAM 3771 §103 Non-Final OA 112d overdue Pending Sep 09, 2021
17470967 CURVED SUTURE NEEDLES HAVING A NON-SMOOTH PROFILE Ergosurgical Group Corp. NEMER, OSAMA MOHAMMAD 3771 §103 Non-Final OA 50d overdue Pending Sep 09, 2021

Managing Dentons US LLP (Joel Bock)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month